Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06674863 · ClinicalTrials.gov registry record · NA
Addressing Health Literacy With a Tailored Survivorship Care Plan
A NA study of Stage IVB Prostate Cancer AJCC v8 and Localized Prostate Carcinoma, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 3
- Study locations
NCT06674863: Recruiting NA study of Stage IVB Prostate Cancer AJCC v8 and Localized Prostate Carcinoma, sponsored by Emory University.
NCT06674863 is a NA study of Stage IVB Prostate Cancer AJCC v8 and Localized Prostate Carcinoma that is actively recruiting participants, run by Emory University. The registered enrollment target is 150 participants, below the 174-participant average among 45 other Stage IVB Prostate Cancer AJCC v8 trials with a reported enrollment target (14% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06674863, a NA study of Stage IVB Prostate Cancer AJCC v8 and Localized Prostate Carcinoma, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 3
- Study locations
Study Summary
This clinical trial compares the impact of a tailored survivorship care plan (SCP) to a standard SCP on the understanding of and access to survivorship care in black or African American patients with prostate cancer that has not spread to other parts of the body (localized) or that has spread from where it first started (primary site) to a limited number of places in the body (oligometastatic). SCPs summarize treatment history and recommendations for monitoring and maintaining health, and may also include potential long term effects of treatments received. The intention of a SCP is to help patients participate in their own health care. However, many patients have below basic levels of health literacy, meaning, they have a lower ability to obtain, communicate, process and understand basic health information and services to make health decisions. In fact, poor health literacy has been linked with worse quality of life in prostate cancer survivors. A tailored SCP includes the addition of an educational supplement based on lower reading and writing skills (low literacy) and may address health literacy barriers to understanding of treatment options and side effects. A standard SCP uses a template based on the American Society of Clinical Oncology (ASCO) guidelines for prostate cancer. A tailored SCP with low literacy educational supplements may be more effective compared to a standard SCP in improving understanding and access to survivorship care in black or African American patients with localized or oligometastatic prostate cancer.
Primary Outcome
Comprehension will be scored as dichotomous variables, correct or incorrect. The proportion of patients who correctly understand after the standard survivorship care plan (SCP) compared to the proportion who correctly understand after the standard SCP + tailoring + educational support will be analyzed using a two-tailed Z-score test for equality of two proportions at a significance level of P \< 0.05.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Supportive Care
- OTHER Educational Intervention
- OTHER Interview
Study Locations (3)
Georgia
- Grady Memorial Hospital - Atlanta
- Emory University Hospital/Winship Cancer Institute - Atlanta
- Atlanta VA Medical Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-11-07 |
| Est. Completion | 2030-12-31 |
| Phase | NA |
What NCT06674863 shows while recruiting
NCT06674863 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 174-participant average among 45 other Stage IVB Prostate Cancer AJCC v8 trials with a reported enrollment target (14% lower).
The record links to 3 conditions, with Stage IVB Prostate Cancer AJCC v8 appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT06674863 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06674863 about?
NCT06674863 is a clinical study titled "Addressing Health Literacy With a Tailored Survivorship Care Plan". This clinical trial compares the impact of a tailored survivorship care plan (SCP) to a standard SCP on the understanding of and access to survivorship care in black or African American patients with prostate cancer that has not spread to other parts of the body (localized) or that has spread from w...
What is the current status of trial NCT06674863?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-11-07. Estimated completion is 2030-12-31.
What conditions does trial NCT06674863 study?
This clinical trial studies the following conditions: Stage IVB Prostate Cancer AJCC v8, Localized Prostate Carcinoma, Oligometastatic Prostate Carcinoma.
What interventions are being tested in trial NCT06674863?
The interventions under investigation include: Questionnaire Administration (OTHER), Supportive Care (OTHER), Educational Intervention (OTHER), Interview (OTHER).
Who is sponsoring clinical trial NCT06674863?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06674863 being conducted?
This trial has 3 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage IVB Prostate Cancer AJCC v8
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06674863's enrollment target sits among peer trials
150 11th of 45 higher than 35 of 45 other Stage IVB Prostate Cancer AJCC v8 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stage IVB Prostate Cancer AJCC v8 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
RECRUITING
-
PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer
RECRUITING · Phase 1
-
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
RECRUITING · Phase 2
-
Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy
RECRUITING · Phase 1
-
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
RECRUITING · Phase 2
-
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI